Who invested in Vazyme Biotech?
Vazyme Biotech's investors include GF Xinde Investment Management and Sherpa Healthcare Partners.
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$84Mraised across 1 round since 2020, from 1 source
Vazyme Biotech's investors include GF Xinde Investment Management and Sherpa Healthcare Partners.
Vazyme Biotech has raised $84M across 1 round since 2020.
Vazyme Biotech's most recent round was a Series C of $84M in Dec 2020.
Its most recent round, $84M in Dec 2020, is also its largest on record.
Vazyme Biotech's first round on record, in Dec 2020, was backed by GF Xinde Investment Management and Sherpa Healthcare Partners.
Vazyme Biotech's latest named round is a Series C, in Dec 2020.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.